Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Strom

Showing results (11-20 of 656) with videos related to

Pageof 66
Sort By:
Transplantation Proceedings|February 1, 1993
Summation of the biologic aspects of the congressT B Strom
Transplantation Proceedings|April 1, 1988
The cellular and molecular basis of allograft rejection: what do we know?T B Strom
Transplantation Proceedings|February 1, 1987
The immunopharmacology of graft rejectionT B Strom
European Quality Assurance Network Newsletter|May 24, 1995
Quality of care for hip fracture patientsB Strom, B Villadsen
Journal of Clinical Immunology|July 1, 1995
Immunobiology and immunopharmacology of organ allograft rejectionM Suthanthiran, T B Strom
Current Opinion in Immunology|October 12, 2010
Immunogenetics and transplantationAllan Kirk, Terry B Strom
Immunotherapy|July 20, 2010
T-cell-directed treatment strategies for Type 1 diabetes and the confounding role of inflammationMaria Koulmanda, Terry B Strom
Pediatric Nephrology (Berlin, Germany)|November 5, 1997
Immunoregulatory drugs: mechanistic basis for use in organ transplantationM Suthanthiran, T B Strom
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 1, 1996
Therapeutic approach to organ transplantationT B Strom, M Suthanthiran
The New England Journal of Medicine|September 13, 1984
Cyclosporine-induced nephrotoxicity. Inevitable and intractable?T B Strom, R Loertscher
Pageof 66

Showing results (11-20 of 656) with videos related to

Sort By:
Pageof 66
Transplantation Proceedings|February 1, 1993
Summation of the biologic aspects of the congressT B Strom
Transplantation Proceedings|April 1, 1988
The cellular and molecular basis of allograft rejection: what do we know?T B Strom
Transplantation Proceedings|February 1, 1987
The immunopharmacology of graft rejectionT B Strom
European Quality Assurance Network Newsletter|May 24, 1995
Quality of care for hip fracture patientsB Strom, B Villadsen
Journal of Clinical Immunology|July 1, 1995
Immunobiology and immunopharmacology of organ allograft rejectionM Suthanthiran, T B Strom
Current Opinion in Immunology|October 12, 2010
Immunogenetics and transplantationAllan Kirk, Terry B Strom
Immunotherapy|July 20, 2010
T-cell-directed treatment strategies for Type 1 diabetes and the confounding role of inflammationMaria Koulmanda, Terry B Strom
Pediatric Nephrology (Berlin, Germany)|November 5, 1997
Immunoregulatory drugs: mechanistic basis for use in organ transplantationM Suthanthiran, T B Strom
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 1, 1996
Therapeutic approach to organ transplantationT B Strom, M Suthanthiran
The New England Journal of Medicine|September 13, 1984
Cyclosporine-induced nephrotoxicity. Inevitable and intractable?T B Strom, R Loertscher
Pageof 66